Form D · Pharmaceuticals

QUINCY BIOSCIENCE HOLDING CO INC

Madison, WI · CIK 0001377795

Offering snapshot reported Dec 15, 2010 · SEC filing

Reported sold
$5.18M
Offering amount: $6.5M
Investors reported
89
Form D · investor count
Minimum accepted
$120K
Reported outside-investor minimum
First sale
May 15, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.59M$5.18MJun 1, 2009: $10,000.00Jun 1, 2009Dec 15, 2010: $5,181,090.00Dec 15, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,000 → $5,181,090

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 15, 2010Amendment$5,181,090$5,171,090vs Jun 1, 200989SEC filing
Jun 1, 2009Initial$10,000No comparisonNot reportedSEC filing
Jun 12, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Oct 2, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-95426
Class B Non-Voting Common Stock ($0.01 par value)

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Dec 15, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael J. Beaman Director, Executive
John Dedrick Director
Robert Flemming Director
Robert Gohsman Director
Robert Moser Director
Robert C. Risch, Jr. Director, Executive
Mark Y. Underwood Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
301 South Westfield Road Suite 200
Madison, WI, 53717